ATB Therapeutics

ATB Therapeutics develops first-in-class biologics incorporating novel cell-killing mechanisms within targeted antibodies. Their proprietary ATBioFarm platform enables scalable, single-step production of these advanced therapeutics, offering potential advancements in oncology and immunology. This innovative approach addresses critical challenges in selecting ADC drug candidates and opens avenues for new mechanisms of action.

Buy Funded Startups lists

Funding Round: Series A

Funding Amount: €54M

Date: 18-Nov-2024

Investors: EQT Life Sciences, MRL Ventures Fund, V-Bio, VIVES Partners, SFPIM, Wallonie Entreprendre, Sambrinvest, existing investors

Markets: Oncology, Immunology, Biotechnology, Health Care, Therapeutics

HQ: Aye, Luxembourg, Belgium

Founded: 2018

Website: https://www.atbtherapeutics.com/

LinkedIn: https://be.linkedin.com/company/atbtherapeutics

Twitter:

Instagram: